InsiderTrades

Form 4 for CHYM Chime Financial, Inc.

Accepted 2025-06-13 00:00:00 ET · period of report 2025-06-13 · accession 0001415889-25-017329 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2025-06-13 2025-06-13 CHYM Feuille James Dir J - Other — 0 0 New —
DI 2025-06-13 2025-06-13 CHYM Feuille James Dir C - Cnv Deriv — +23.77M 23.77M New —
DMI 2025-06-13 2025-06-13 CHYM Feuille James Dir C - Cnv Deriv — -23.62M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-06-13 J A 23,766,254 — 23,766,254 I See footnote — — (F6) Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the IPO. (F4) These shares are held as follows: (i) 7,221,106 shares held by Crosslink Crossover Fund VI, L.P. ("CO VI"); (ii) 10,782,501 shares held by Crosslink Ventures VII, L.P. ("CV VII"); (iii) 4,620,340 shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B"); and (iv) 1,142,307 shares held by Crosslink Bayview VII, LLC ("CB VII"). (F5) The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
2 Common Common Stock 2025-06-13 C A 23,766,254 — 23,766,254 I See footnote — — (F3) Each share of Series B Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date. (F2) Each share of Series A-2 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date. (F1) Each share of Series A Preferred Stock automatically converted into Common Stock on a 1.0089020772-for-1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO") and had no expiration date. (F4) These shares are held as follows: (i) 7,221,106 shares held by Crosslink Crossover Fund VI, L.P. ("CO VI"); (ii) 10,782,501 shares held by Crosslink Ventures VII, L.P. ("CV VII"); (iii) 4,620,340 shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B"); and (iv) 1,142,307 shares held by Crosslink Bayview VII, LLC ("CB VII"). (F5) The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
3 Common Common Stock 2025-06-13 J D 23,766,254 — 0 I See footnote — — (F6) Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the IPO. (F5) The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.
4 Derivative Series B Preferred Stock 2025-06-13 C D 2,385,950 — 0 I See footnote — · — to — 2,385,950 Common Stock (F3) Each share of Series B Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date. (F5) The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein. (F9) These shares were held as follows: (i) 1,554,930 shares held by CV VII; (ii) 666,290 shares held by CV VII-B; and (iii) 164,730 shares held by CB VII.
5 Derivative Series A Preferred Stock 2025-06-13 C D 16,166,706 — 0 I See footnote — · — to — 16,310,624 Common Stock (F1) Each share of Series A Preferred Stock automatically converted into Common Stock on a 1.0089020772-for-1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO") and had no expiration date. (F5) The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein. (F7) These shares were held as follows: (i) 6,555,280 shares held by CO VI; (ii) 6,263,780 shares held by CV VII; (iii) 2,684,056 shares held by CV VII-B; and (iv) 663,590 shares held by CB VII.
6 Derivative Series A-2 Preferred Stock 2025-06-13 C D 5,069,680 — 0 I See footnote — · — to — 5,069,680 Common Stock (F2) Each share of Series A-2 Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the IPO and had no expiration date. (F5) The Reporting Person is: (i) a managing member of Crosslink Ventures VII Holdings, LLC, which is the general partner of CV VII and CV VII-B and the manager of CB VII; and (ii) a fund manager for Crossover Fund VI Management, L.L.C., the general partner of CO VI. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein. (F8) These shares were held as follows: (i) 2,908,030 shares held by CV VII; (ii) 1,246,100 shares held by CV VII-B; (iii) 607,470 shares held by CO VI; and (iv) 308,080 shares held by CB VII.